Neuroprotective effects of folic acid on experimental diabetic peripheral neuropathy

Abstract

Diabetic peripheral neuropathy (DPN) is widely considered as a degenerative complication of diabetic patients. The clinical effectiveness of folic acid (FA) on DPN is uncertain. The objective of the present study was to determine the effect of FA in DPN using electromyography (EMG), histopathological examination, immunohistochemistry, inclined plane test, and malondialdehyde (MDA) levels as a marker for lipid peroxidation in experimental diabetic rats. A total of 21 Sprague Dawley rats were randomly divided into 3 groups: control group, diabetes group, and FA-treated group. In EMG, compound muscle action potential (CMAP) amplitude in the sciatic nerve was lower in the diabetes group compared with the control group. CMAP amplitude in the sciatic nerve was higher in the FA-treated group when compared with the diabetes group. Distal latency and CMAP duration in the sciatic nerve were lower in the FA-treated group when compared with the diabetes group. In histopathological examination of the sciatic nerve, peripheral fibrosis was present in the diabetic group; the fibrosis was lower in the FA-treated group. In comparison with the diabetes group, the expression of nerve growth factor (NGF) was higher in the FA-treated group. The scores for the inclined plane test were lower in the diabetes group and higher in the FA-treated group than the control group. The MDA levels were significantly lower in the FA-treated group when compared with the diabetes group.

The study suggests that FA can protect diabetic rats against DPN and that the underlying mechanism for this may be related to improvement of the expression of NGF and lower MDA levels.

Keywords

Diabetic peripheral neuropathy EMG histopathology inclined plane NGF expression MDA

Get full access to this article

View all access options for this article.

References

Allmark

Bachinski

(1949) A method of assay for curare using rats. Journal of the American Pharmacists Association 38: 43–45.

Alp

Varol

Celik

Altas

Evliyaoglu

Tokgoz

. (2012) Protective effects of beta glucan and gliclazide on brain tissue and sciatic nerve of diabetic rats induced by streptozosin. Experimental Diabetes Research 2012: 230342.

Bederson

Pitts

Tsuji

Nishimura

Davis

Bartkowski

(1986) Rat middle cerebral artery occlusion: evaluation of the model and development of a neurologic examination. Stroke 17(3): 472–476.

Brocardo

Budni

Pavesi

Franco

Uliano-Silva

Trevisan

. (2010) Folic acid administration prevents ouabain-induced hyperlocomotion and alterations in oxidative stress markers in the rat brain. Bipolar Disorders 12(4): 414–424.

Cankayali

Dogan

Solak

Demirag

Eris

Demirgoren

Moral

(2007) Neuromuscular deterioration in the early stage of sepsis in rats. Critical Care 11(1): 1–7.

Confer

Wolcott

Hayes

(2012) Critical illness polyneuromyopathy. American Journal of Health-System Pharmacy 69(14): 1199–1205.

Couto

Gonçalves

Catarino

Araújo

Correia-Branco

Martel

(2012) The effect of oxidative stress upon the intestinal uptake of folic acid: in vitro studies with Caco-2 cells. Cell Biology and Toxicology 28(6): 369–381.

Dai

Steyger

Wang

Vass

Nuttall

(2004) Expression of Trk A receptors in the mammalian inner ear. Hearing Research 187 (1–2): 1–11.

Dyck

Kratz

Karnes

Litchy

Klein

Pach

. (1993) The prevalence by staged severity of various types of diabetic neuropathy, retinopathy, and nephropathy in a population- based cohort: the Rochester diabetic neuropathy study. Neurology 43(4): 817–824.

10.

Figueroa-Romero

Sadidi

Feldman

(2008) Mechanisms of disease: the oxidative stress theory of diabetic neuropathy. Reviews in Endocrine and Metabolic Disorders 9(4): 301–314.

11.

Giacco

Brownlee

(2010) Oxidative stress and diabetic complications. Circulation Research 107(9): 1058–1070.

12.

Ashline

Dhitavat

Ortiz

Collins

Shea

. (2003) Folate deprivation induces neurodegeneration: roles of oxidative stress and increased homocysteine. Neurobiology of Disease 14(1): 32–42.

13.

Iskandar

Nelson

Resnick

Skene

Gao

Johnson

. (2004) Folic acid supplementation enhances repair of the adult central nervous system. Annals of Neurology 56(2): 221–227.

14.

Kovrazhkina

(2012) Demyelinating polyneuropathies in patients with diabetes mellitus and chronic alcoholic intoxication. Zhurnal Nevrologii i Psikhiatrii Imeni S.S. Korsakova 112(5): 41–45.

15.

López-Hernández

García-Escrivá

Pampliega-Pérez

Alvarez-Saúco

Martín-Estefanía

Asensio-Asensio

(2003) Peripheral and optical myeloneuropathy in a folic acid deficient alcoholic patient. Revue Neurologique 37(8): 726–729.

16.

Xiang

Yuan

Guo

Xiao

. (2009) Neuroprotection of soyabean isoflavone co-administration with folic acid against beta-amyloid 1-40-induced neurotoxicity in rats. British Journal of Nutrition 102(4): 502–505.

17.

Malik

Tesfaye

Newrick

Walker

Rajbhandari

Siddique

. (2005) Sural nerve pathology in diabetic patients with minimal but progressive neuropathy. Diabetologia 48(3): 578–585.

18.

Manschot

Biessels

Rutten

Kessels

Gispen

Kappelle

(2008) Peripheral and central neurologic complications in type 2 diabetes mellitus: no association in individual patients. Journal of the Neurological Sciences 264 (1–2): 157–162.

19.

Mastroiacovo

Leoncini

(2011) More folic acid, the five questions: why, who, when, how much, and how. Biofactors 37(4): 272–279.

20.

Olaleye

Perkins

Bril

(2001) Evaluation of three screening tests and a risk assessment model for diagnosing peripheral neuropathy in the diabetes clinic. Diabetes Research and Clinical Practice 54(2): 115–128.

21.

Perkins

Bril

(2005) Emerging therapies for diabetic neuropathy: a clinical overview. Current Diabetes Reviews 1(3): 271–280.

22.

Pravenec

Kozich

Krijt

Sokolová

Zídek

Landa

. (2013) Folate deficiency is associated with oxidative stress, increased blood pressure, and insulin resistance in spontaneously hypertensive rats. American Journal of Hypertension 26(1): 135–140.

23.

Reynolds

(2002) Folic acid, aging depression and dementia. British Journal of Nutrition 324(7352): 1512–1515.

24.

Rivlin

Tator

(1977) Objective clinical assesment of motor function after experimental spinal cord injury in the rat. Journal of Neurosurgery 47: 577–581.

25.

Sima

(2003) New insights into the metabolic and molecular basis for diabetic neuropathy. Cellular and Molecular Life Sciences 60(11): 2445–2464.

26.

Sousa

Du Yan

Fernandes

Guimaraes

Stern

Saraiva

(2001) Familial amyloid polyneuropathy: receptor for advanced glycation end products-dependent triggering of neuronal inflammatory and apoptotic pathways. Journal of Neuroscience 21(19): 7576–7586.

27.

Van Guelpen

Hultdin

Johansson

Stegmayr

Hallmans

Nilsson

. (2005) Folate, vitamin B12 and risk of ischemic and hemorrhagic stroke: a prospective, nested case-referent study of plasma concentrations and dietary intake. Stroke 36(7): 1426–1431.

28.

Wayhs

Tortato

Mescka

Pasquali

Schnorr

Nin

. (2013) The association effect of insulin and clonazepam on oxidative stress in liver of an experimental animal model of diabetes and depression. Pharmaceutical Biology 51(5): 533–538.

29.

Yagci

Gunduz

Sancak

Agirman

Mesci

Akyuz

(2010) Comparative electrophysiological techniques in the diagnosis of carpal tunnel syndrome in patients with diabetic polyneuropathy. Diabetes Research and Clinical Practice 88(2): 157–163.

30.

Yonemori

Yamaguchi

Yamada

Tamura

(1998) Evaluation of a motor deficit after chronic focal cerebral ischemia in rats. Journal of Cerebral Blood Flow and Metabolism 18(10): 1099–1106.